Category: NovoCure

NovoCure (Nasdaq: NVCR) today announced good results in its pancreatic cancer trial. This announcement comes after the approval granted two months ago to sell the lung cancer treatment. NovoCure’s stock price is currently up more than 30% on the Nasdaq, giving the company a market cap of $2.83 billion. The…